ENGN Wutah pendapatan kuartal marang kuartal enGene Holdings Inc

ENGN (enGene Holdings Inc) - tandha merek perusahaan

Quarterly revenue growth for enGene Holdings Inc. (ENGN) demonstrates volatility, as the absence of commercial products and reliance on external funding render cash flows unpredictable. The 0.00 mark characterizes this parameter, while the market has already priced in current losses and the anticipation of patent data regarding cancer treatment. The valuation is fundamentally supported by a high scientific reputation in the development of safe gene vectors.

ENGN (enGene Holdings Inc) riwayat Owah-owahan pendapatan dibandhingake kuartal kepungkur saka 21.02.2024 nganti 21.11.2026

Rincian metrik keuangan lan pasar enGene (ENGN)

- data kapitalisasi pasar:
Analisis dhasar perusahaan:enGene Holdings Inc. - ENGN
Produk seri engene.com

This metric is calculated as the percentage change in current quarter revenue relative to the same period last year, measuring the pace of business expansion. This metric identifies a fading operational momentum, warning the investor of the risk of capital stagnation before a shift in the market cycle. For enGene Holdings Inc. (ENGN), sales growth confirms the commercial demand for the non-viral DEP platform in cancer therapy. By analyzing the percentage increase in quarterly sales, one can assess the effectiveness of the implementation of mucosal drugs.

Perusahaan pesaing

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|dianthustx.com (DNTH) - Wutah pendapatan triwulanan|PHVS (Pharvaris NV) - Wutah pendapatan triwulanan|ABCL: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PHAR (Pharming Corp)|nektar.com (NKTR) - Tingkat wutah pendapatan sajrone kuartal|UPB - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ZBIO (Zenas Biopharma)|IMNM: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Gossamer Bio, Inc. (GOSS)|Wutah pendapatan kuartal marang kuartal KalVista Pharmaceuticals|Septerna Inc (SEPN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PVLA|SVRA (Savara) - Tambahing pendapatan triwulanan|Rigel Pharma - Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal AnaptysBio Corp (ANAB)|ATXS: Wutah dodolan triwulanan|RAPT Therapeutics Inc. (RAPT) - Wutah dodolan triwulanan|JBIO (Aerovate Therapeutics) - Wutah dodolan triwulanan|ACRS: Owah-owahan dodolan kuartal marang kuartal|KYTX (Kyverna Therapeutics, Inc) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal TLSA (Tiziana Life Sciences PLC)|Wutah pendapatan triwulanan CABA|Wutah pendapatan kuartal marang kuartal VTYX (Ventyx Biosciences, Inc.)|Wutah pendapatan kuartal marang kuartal Theratechnologies Inc THTX|Tingkat wutah dodolan sajrone kuartal Avalo Therapeutics, Inc. (AVTX)|ELDN - Wutah pendapatan kuartal marang kuartal|AGEN - Wutah pendapatan triwulanan|climbbio.com (CLYM) - Wutah pendapatan kuartal marang kuartal|Zura Bio - Tambahing pendapatan triwulanan|ATYR (atyrpharma.com) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADAG (Adagene)|Wutah pendapatan triwulanan IMA|STTK (Shattuck Labs) - Tambahing pendapatan triwulanan|Equillium Inc - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan CNTB|IMUX - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ATRA|IFRX (InflaRx) - Wutah dodolan triwulanan|X4 Pharma (XFOR) - Wutah pendapatan triwulanan|ACET (Adicet) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan celularity.com (CELU)|Wutah pendapatan kuartal marang kuartal INmune Bio Inc (INMB)|Tingkat wutah dodolan sajrone kuartal Barinthus Biotherapeutics PLC|Wutah pendapatan kuartal marang kuartal Kezar Life Sciences Inc KZR|Tambahing pendapatan triwulanan SABS|AKTX - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ENLV (enlivex.com)|QTTB: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal GOVX|Wutah dodolan triwulanan EDSA|Wutah dodolan kuartal marang kuartal IBIO (iBio Corp)|Wutah pendapatan kuartal marang kuartal Carisma Therapeutics Inc (CARM)|Tingkat wutah dodolan sajrone kuartal xtlbio.com|Bolt Biotherapeutics Inc. - Wutah dodolan triwulanan|HCW Biologics Inc (HCWB) - Tingkat wutah pendapatan sajrone kuartal|Aptevo - Wutah pendapatan triwulanan|AIM ImmunoTech (AIM) - Wutah dodolan triwulanan|Aditxt Corp (ADTX) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal GRI|Wutah dodolan triwulanan XRTX|Tingkat wutah pendapatan sajrone kuartal Vyome Holdings Inc. HIND|Wutah pendapatan triwulanan REVB|Tingkat wutah dodolan sajrone kuartal Indaptus Corp|BiondVax Pharmaceuticals - Wutah dodolan triwulanan|CalciMedica Corp (CALI) - Tingkat wutah pendapatan sajrone kuartal|Affimed - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal allakos.com ALLK|HOOKIPA Pharma (HOOK) - Wutah pendapatan kuartal marang kuartal|IGMS (IGM Biosciences Inc.) - Wutah pendapatan kuartal marang kuartal|ITOS (iTeos Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal OCEA (Ocean Biomedical)|Wutah pendapatan kuartal marang kuartal TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan